本頁面由Tiger Trade Technology Pte. Ltd.提供服務

XILIO THERAPEUTICS, INC.

9.03
+0.10001.12%
盤後9.030.00000.00%19:30 EDT
成交量:1.73萬
成交額:15.59萬
市值:5,941.88萬
市盈率:-2.72
高:9.03
開:8.93
低:8.93
收:8.93
52周最高:12.74
52周最低:6.47
股本:658.02萬
流通股本:340.25萬
量比:1.88
換手率:0.51%
股息:- -
股息率:- -
每股收益(TTM):-3.3174
每股收益(LYR):-15.2374
淨資產收益率:-55.03%
總資產收益率:-13.61%
市淨率:0.82
市盈率(LYR):-0.59

資料載入中...

2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

SEC問詢函

Form CORRESP - Correspondence
2024/04/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/10

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/10

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]